126 related articles for article (PubMed ID: 14668058)
1. Effects of membrane type and liquid/liquid phase boundary on in vitro release of ketoprofen from gel formulations.
Gallagher SJ; Trottet L; Carter TP; Heard CM
J Drug Target; 2003 Jul; 11(6):373-9. PubMed ID: 14668058
[TBL] [Abstract][Full Text] [Related]
2. Ketoprofen: release from, permeation across and rheology of simple gel formulations that simulate increasing dryness.
Gallagher SJ; Trottet L; Heard CM
Int J Pharm; 2003 Dec; 268(1-2):37-45. PubMed ID: 14643975
[TBL] [Abstract][Full Text] [Related]
3. Characterization of new topical ketoprofen formulations prepared by drug entrapment in solid lipid matrices.
Argemí A; Domingo C; de Sousa AR; Duarte CM; García-González CA; Saurina J
J Pharm Sci; 2011 Nov; 100(11):4783-9. PubMed ID: 21710507
[TBL] [Abstract][Full Text] [Related]
4. Solvent content and macroviscosity effects on the in vitro transcutaneous delivery and skin distribution of ketoprofen from simple gel formulations.
Gallagher SJ; Heard CM
Skin Pharmacol Physiol; 2005; 18(4):186-94. PubMed ID: 15908759
[TBL] [Abstract][Full Text] [Related]
5. Release of ketoprofen enantiomers from HPMC K100M matrices--diffusion studies.
Solinís MA; de la Cruz Y; Hernández RM; Gascón AR; Calvo B; Pedraz JL
Int J Pharm; 2002 Jun; 239(1-2):61-8. PubMed ID: 12052691
[TBL] [Abstract][Full Text] [Related]
6. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
Nikumbh KV; Sevankar SG; Patil MP
Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
[TBL] [Abstract][Full Text] [Related]
7. The delivery of ketoprofen from a system containing ion-exchange fibers.
Yu L; Li S; Yuan Y; Dai Y; Liu H
Int J Pharm; 2006 Aug; 319(1-2):107-13. PubMed ID: 16701973
[TBL] [Abstract][Full Text] [Related]
8. [The evaluation of ketoprofen pharmaceutical availability in the presence of a dry extract from goldenrod (Solidago virgaurea L.) of synthetic polymer vehicles].
Berner-Strzelczyk A; Kołodziejska J; Piechota-Urbańska M; Zgoda MM
Polim Med; 2009; 39(4):39-44. PubMed ID: 20099734
[TBL] [Abstract][Full Text] [Related]
9. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
[TBL] [Abstract][Full Text] [Related]
11. Permeation of naproxen from saturated solutions and commercial formulations through synthetic membranes.
Farinha A; Toscano C; Campos R; Bica A; Hadgraft J
Drug Dev Ind Pharm; 2003 Apr; 29(4):489-94. PubMed ID: 12737541
[TBL] [Abstract][Full Text] [Related]
12. In vitro-in vivo evaluation of in situ gelling and thermosensitive ketoprofen liquid suppositories.
Ozgüney I; Kardhiqi A; Yıldız G; Ertan G
Eur J Drug Metab Pharmacokinet; 2014 Dec; 39(4):283-91. PubMed ID: 24096820
[TBL] [Abstract][Full Text] [Related]
13. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
Singh SK; Durrani MJ; Reddy IK; Khan MA
Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
[TBL] [Abstract][Full Text] [Related]
14. Film drying and complexation effects in the simultaneous skin permeation of ketoprofen and propylene glycol from simple gel formulations.
Bowen JL; Heard CM
Int J Pharm; 2006 Jan; 307(2):251-7. PubMed ID: 16289881
[TBL] [Abstract][Full Text] [Related]
15. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels.
Cevc G; Mazgareanu S; Rother M
Int J Pharm; 2008 Aug; 360(1-2):29-39. PubMed ID: 18337027
[TBL] [Abstract][Full Text] [Related]
16. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
Cevc G; Vierl U; Mazgareanu S
Int J Pharm; 2008 Aug; 360(1-2):18-28. PubMed ID: 18524509
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the utility of an in vitro release test for optimizing semisolid dosage forms.
Proniuk S; Dixon SE; Blanchard J
Pharm Dev Technol; 2001 Aug; 6(3):469-76. PubMed ID: 11485188
[TBL] [Abstract][Full Text] [Related]
18. Elimination of ketoprofen from the stratum corneum after topical administration with ketoprofen formulations in human subjects.
Takeshi M; Ebihara T; Maekawa K; Yamamoto K; Higo N
Int J Pharm; 2014 Apr; 465(1-2):197-201. PubMed ID: 24530385
[TBL] [Abstract][Full Text] [Related]
19. Design and characterization of sustained release ketoprofen entrapped carnauba wax microparticles.
Oliveira RB; Nascimento TL; Lima EM
Drug Dev Ind Pharm; 2012 Jan; 38(1):1-11. PubMed ID: 21671838
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a new topical gel-spray formulation of ketoprofen lysine salt in the rat: percutaneous permeation in vitro and in vivo and pharmacological activity.
Porzio S; Caselli G; Pellegrini L; Pallottini V; Del Rosario M; Coppola A; Boltri L; Gentile M; Clavenna G; Melillo G
Pharmacol Res; 1998 Jan; 37(1):41-7. PubMed ID: 9503479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
